| abstract |
The present invention relates to a method of treating cancer in a subject. In certain embodiments, the present invention is a method of treating a particular cancer in a subject, wherein the subject has a high affinity binding agent for MT1-MMP such as BT1718 or a pharmaceutically acceptable salt thereof or According to another embodiment that provides a method comprising administering an effective amount of a drug conjugate comprising a composition, the invention is BT1718 or a pharmaceutically acceptable salt thereof, and pharmaceutically acceptable. A composition comprising a carrier, an adjuvant, or a vehicle is provided. |